<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01530724</url>
  </required_header>
  <id_info>
    <org_study_id>ISF256/09</org_study_id>
    <secondary_id>256/09</secondary_id>
    <nct_id>NCT01530724</nct_id>
  </id_info>
  <brief_title>Diet and Body Composition</brief_title>
  <acronym>CENTRAL</acronym>
  <official_title>Effect of Weight-loss Diet Strategies and Exercise on Dynamics of Body Fat Depots and Metabolic Rate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ben-Gurion University of the Negev</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ben-Gurion University of the Negev</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that differential dynamics in fat depots in response to two&#xD;
      opposing dietary strategies mediate the beneficial metabolic effects during weight loss and&#xD;
      regain phases.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body fat composition</measure>
    <time_frame>0, 6,18 months</time_frame>
    <description>changes in body fat (MRI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>obesity</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>changes in weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>abdominal obesity</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>changes in waist circumference</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes in lipid biomarkers: total cholesterol (mg/dL), triglycerides (mg/dL), HDLc (mg/dL), LDLc (mg/dL) (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes in fasting glucose (mg/dL) (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes in insulin (μIU/mL) (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory state</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes hsCRP (mg/L) (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolomic</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes in sub-lipids (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolomic</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes in sub-proteins ( blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver function (blood biomarkers)</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>Changes in ALT (U/l), AST (U/l), ALKP (U/I), GGT (U/l) (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetic signature</measure>
    <time_frame>baseline</time_frame>
    <description>SNPs (variants) associated with fat distribution and visceral fat (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epigenetics</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>changes in genes' methylation (blood draw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epigenetics</measure>
    <time_frame>0, 6, 18 months</time_frame>
    <description>changes in mRNAs (blood draw)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">224</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>low fat diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Weight-loss diet strategy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low carb diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Weight-loss diet strategy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Weight-loss diet strategy (+) exercise (PA)</intervention_name>
    <description>Weight-loss diet strategy with a free gym membership; monthly 60-minute educational workshops; 3 sessions of workout per week of mostly aerobic training</description>
    <arm_group_label>low carb diet</arm_group_label>
    <arm_group_label>low fat diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>weight loss (-) exercise (PA)</intervention_name>
    <description>Weight-loss diet strategy without exercise</description>
    <arm_group_label>low carb diet</arm_group_label>
    <arm_group_label>low fat diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elevated waist circumference:&#xD;
&#xD;
               -  Men: &gt; 40 inches (102 cm)&#xD;
&#xD;
               -  Women&gt; 35 inches (88 cm)&#xD;
&#xD;
          -  Poor dieters with TG&gt;150mg/dL and high-density-lipoprotein cholesterol [HDL-c] &lt;40&#xD;
             mg/dL for men and &lt;50 mg/dL for women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Serum creatinine LT 2 mg/dl&#xD;
&#xD;
          -  Disturbed liver function (LT 3 fold level of ALT and AST enzymes)&#xD;
&#xD;
          -  Active cancer&#xD;
&#xD;
          -  Individuals who cannot start physical activity in the gym&#xD;
&#xD;
          -  Individuals that are highly physically active (more than 4 hours/week)&#xD;
&#xD;
          -  Active in other nutritional trial&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>nuclear research center Negev</name>
      <address>
        <city>Dimona</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229-41. doi: 10.1056/NEJMoa0708681. Erratum in: N Engl J Med. 2009 Dec 31;361(27):2681.</citation>
    <PMID>18635428</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 8, 2012</study_first_submitted>
  <study_first_submitted_qc>February 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ben-Gurion University of the Negev</investigator_affiliation>
    <investigator_full_name>Iris Shai</investigator_full_name>
    <investigator_title>Iris Shai, RD PhD</investigator_title>
  </responsible_party>
  <keyword>abdominal obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

